Clinical Trial: EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT06897488) titled 'EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial' on March 25.

Brief Summary: This clinical research study is to learn about the effects of giving radiotherapy alone after lumpectomy to patients who have early-stage, low-risk breast cancers and who are 60 years of age or older.

Study Start Date: Sept. 01, 2025

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: RADIATION: Adjuvant Radiotherapy

Participants will receive treatment following Lumpectomy

Recruitment Status: NOT_YET_RECRUITING

Sponsor: M.D. Anderson ...